FTO and acute myeloid leukemia: On the one hand, NPM1 mutant A can promote cell cycle and inhibit apoptosis by upregulating FTO, reducing m6A levels, and activating the PDGFRb/extracellular signal regulated kinase (ERK) signalling axis, which in turn maintains AML cell viability [102].